XAROPE VICK 16 MG/ML XPE FR PLAS TRANS X 100 ML ( MEL)

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1214200150055
  • GGREM 528722070006807
  • Código de barras 7500435209786

O que a fonte publica

Detentor do registro
PROCTER & GAMBLE DO BRASIL LTDA
Princípios ativos
GUAIFENESINA
Embalagem
16 MG/ML XPE FR PLAS TRANS X 100 ML ( MEL)
Regime de dispensação
Tarja Sem Tarja
Tipo de produto
Novo
Classe terapêutica
R5C - EXPECTORANTES
Prescrição
Isento de prescrição

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:528722070006807
{
  "name": "XAROPE VICK 16 MG/ML XPE FR PLAS TRANS X 100 ML ( MEL)",
  "holder": "PROCTER & GAMBLE DO BRASIL LTDA",
  "stripe": "Tarja Sem Tarja",
  "barcodes": [
    "7500435209786"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "528722070006807",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "59.476.770/0001-58",
  "priceRegime": "Liberado",
  "productName": "XAROPE VICK",
  "productType": "Novo",
  "hospitalOnly": false,
  "presentation": "16 MG/ML XPE FR PLAS TRANS X 100 ML ( MEL)",
  "sourceStatus": null,
  "supplyRegime": "Tarja Sem Tarja",
  "factoryPrices": {
    "icms-0": "27.65",
    "icms-12": "31.42",
    "icms-17": "33.31",
    "icms-18": "33.72",
    "icms-19": "34.14",
    "icms-20": "34.56",
    "icms-21": "35.00",
    "icms-22": "35.45",
    "icms-23": "35.91",
    "icms-17.5": "33.52",
    "icms-19.5": "34.35",
    "icms-20.5": "34.78",
    "icms-22.5": "35.68",
    "icms-12-alc": "28.05",
    "icms-17-alc": "29.74",
    "icms-18-alc": "30.11",
    "icms-19-alc": "30.48",
    "icms-20-alc": "30.86",
    "icms-21-alc": "31.25",
    "icms-22-alc": "31.65",
    "icms-23-alc": "32.06",
    "withoutTaxes": "24.69",
    "icms-17.5-alc": "29.92",
    "icms-19.5-alc": "30.67",
    "icms-20.5-alc": "31.05",
    "icms-22.5-alc": "31.85"
  },
  "pisCofinsList": "Negativa",
  "substanceText": "GUAIFENESINA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "37.09",
    "icms-12": "42.15",
    "icms-17": "44.68",
    "icms-18": "45.23",
    "icms-19": "45.80",
    "icms-20": "46.36",
    "icms-21": "46.95",
    "icms-22": "47.55",
    "icms-23": "48.17",
    "icms-17.5": "44.97",
    "icms-19.5": "46.08",
    "icms-20.5": "46.66",
    "icms-22.5": "47.86",
    "icms-12-alc": "38.78",
    "icms-17-alc": "41.11",
    "icms-18-alc": "41.63",
    "icms-19-alc": "42.14",
    "icms-20-alc": "42.66",
    "icms-21-alc": "43.20",
    "icms-22-alc": "43.75",
    "icms-23-alc": "44.32",
    "withoutTaxes": "34.13",
    "icms-17.5-alc": "41.36",
    "icms-19.5-alc": "42.40",
    "icms-20.5-alc": "42.92",
    "icms-22.5-alc": "44.03"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "GUAIFENESINA"
  ],
  "therapeuticClass": "R5C - EXPECTORANTES",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1214200150055",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "non-prescription",
  "prescriptionRequired": false,
  "therapeuticClassCode": "R5C",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:528722070006807"